The effect of mindfulness therapy on psychological problems of patients with gastrointestinal cancers

effectiveness of mindfulness Based Cancer Recovery on depression, anxiety, stress, pain and quality of life in colon and stomach cancer patients

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200211046458N1

Enrollment

Registered

2021-01-27

Start date

2021-02-03

Completion date

Unknown

Last updated

2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: gastric cancer. Condition 2: Colon Cancer. Malignant neoplasm of stomach Malignant neoplasm of colon

Interventions

Intervention 1: Intervention group: Includes chemotherapy and psychological intervention. In Psychological intervention will use mindfulness - Based Cancer Recovery (MBSR), which is an 8-session inter

Eligibility

Sex/Gender

All

Age

20 Years to 65 Years

Inclusion criteria

Inclusion criteria: Age over 20 years and under 65 years Have a minimum education in reading and writing in order to answer the questionnaires Definitive diagnosis of one of the stomach or intestinal cancers Simultaneous administration of chemotherapy moderate depression and anxiety scores Do not participate in any yoga and meditation classes in the last 6 months Willingness to complete intervention sessions Physical ability to attend 45-minute sessions

Exclusion criteria

Exclusion criteria: Existence of a severe mental illness (presence of any period of mania or hypomania, psychotic disorder and substance use disorders) comorbid of a severe physical illness (other than gastrointestinal cancers) Consumption of psychiatric drugs Receive any other type of psychotherapy at the same time Occurrence of an important stressful event in life (such as the death of a loved one) during treatment Two recurrent absences in treatment sessions

Design outcomes

Primary

Measure	Time frame
Quality of Life. Timepoint: Before the intervention, after the intervention (60days after the first evaluation), 60 days after the intervention. Method of measurement: Quality of Life Questionnaire (EOROTC QLQ-C30).;Pain. Timepoint: Before the intervention, after the intervention (60 days after the first evaluation), 60 days after the intervention. Method of measurement: West Hawn-Yale Multidimensional Pain Questionnaire.;Psychological problems (depression, anxiety and stress). Timepoint: Before the intervention, after the intervention (60 days after the first evaluation), 60 days after the intervention. Method of measurement: Depression, Anxiety, and Stress Scale (DASS-21).	—

Measure

Time frame

Quality of Life. Timepoint: Before the intervention, after the intervention (60days after the first evaluation), 60 days after the intervention. Method of measurement: Quality of Life Questionnaire (EOROTC QLQ-C30).;Pain. Timepoint: Before the intervention, after the intervention (60 days after the first evaluation), 60 days after the intervention. Method of measurement: West Hawn-Yale Multidimensional Pain Questionnaire.;Psychological problems (depression, anxiety and stress). Timepoint: Before the intervention, after the intervention (60 days after the first evaluation), 60 days after the intervention. Method of measurement: Depression, Anxiety, and Stress Scale (DASS-21).

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAbbas Masjedi Arani

Shahid Beheshti University of Medical Sciences

doctormasjedi@gmail.com+98 21 23871

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026